The observation that interferon-gamma (IFN-gamma) inhibits cell prolif
eration and collagen synthesis of a variety of cell types in culture h
as suggested that IFN-gamma may be useful in the treatment of fibropro
liferative diseases. We administered recombinant IFN-gamma subcutaneou
sly (10(5) U/kg/day for 3 days) to rats, beginning one day after the i
nduction of mesangial proliferative nephritis with anti-Thy 1 antibody
. IFN-gamma reduced glomerular (primarily mesangial) cell proliferatio
n by 44% at days 2 and 4 compared to vehicle injected control rats wit
h anti-Thy 1 nephritis (that is, proliferating cells that excluded the
macrophage marker, ED-1, P < 0.001). Despite the inhibition of mesang
ial cell proliferation, IFN-gamma did not reduce the overall extracell
ular matrix deposition (by silver stain) or deposition of type IV coll
agen or laminin (by immunostaining) at 4 or 7 days, and glomerular typ
e IV collagen and laminin mRNA levels were increased (1.4 and 1.7-fold
) at 4 days relative to controls. The inability of IFN-gamma treatment
to reduce mesangial matrix expansion may relate to the fact that IFN-
gamma treated rats had a twofold increase in glomerular macrophages (t
hat is, ED-1 positive cells, P < 0.001 at 2 and 4 days) with an increa
se in oxidant producing cells (day 2, P < 0.05) and a 1.6-fold increas
e in glomerular TGF-beta mRNA expression (4 days). This suggests that
the effect of IFN-gamma to inhibit mesangial cell proliferation in glo
merulonephritis may be offset by the ability of IFN-gamma to increase
glomerular macrophages and TGF-beta expression. These data also show t
hat IFN-gamma can partly dissociate the mesangial proliferative respon
se from the extracellular matrix expansion in glomerulonephritis.